Doctor profile · Federal record
Dr. Seth Pollack, MD
Hematology & Oncology Physician (CMS: Internal Medicine) · Medical Oncology Physician · Chicago, IL
- NPI 1528234143
- Accepts Medicare
- MIPS 91.3 / 100 · 2023
- 21 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
676 N Saint Clair St Ste 850
Chicago, IL 606113124
(312) 695-6180
fax (312) 695-6187 - Additional location
-
1100 Fairview Ave N, D3-100
Seattle, WA 981094433
(206) 667-6629
Credentials & registration
- NPI registered
- May 2008 — 18 yrs on file
- Profile last updated
- January 7, 2021
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Illinois #036154157 · Washington #MD60006970
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1528234143. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
33,956
Distinct HCPCS
10
Medicare allowed
$765,003
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 10,500 | 14 | $1 | |
J9299 |
Injection, nivolumab, 1 mg | 6,680 | 12 | $30 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 4,500 | 20 | $48 | |
J1453 |
Injection, fosaprepitant, 1 mg | 4,200 | 22 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 2,800 | 13 | $54 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,340 | 30 | $45 | |
J9041 |
Injection, bortezomib, 0.1 mg | 593 | 14 | $4 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 420 | 36 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 320 | 30 | $1 | |
J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg | 250 | 35 | $6 |
In context: peer comparison
Among 77 peers in Chicago Hematology & Oncology Physician, average services per provider: 870. This provider delivers 39× the peer median.Open Payments
Industry payments received
All-time total
$52,993
Transactions
47
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SpringWorks Therapeutics, INC. | 12 | $19,988.98 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 12 | $12,992.00 | |
| Deciphera Pharmaceuticals INC. | 13 | $10,155.46 | |
| Ipsen Biopharmaceuticals, INC | 5 | $6,532.74 | |
| Daiichi Sankyo INC. | 4 | $3,273.29 | |
| Aadi Bioscience, INC. | 1 | $50.87 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
11
Patients
0
Total drug cost
$21,714
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Imatinib Mesylate | Generic | 11 | 0 | $21,714 |
Frequently asked questions
What is Dr. Seth Pollack's medical specialty?
Dr. Seth Pollack practices Hematology & Oncology Physician in Chicago, IL.
Where does Dr. Seth Pollack practice?
Dr. Seth Pollack practices at 676 N Saint Clair St Ste 850, Chicago, IL 606113124. Office phone: 3126956180.
What is Dr. Seth Pollack's NPI?
Dr. Seth Pollack's National Provider Identifier (NPI) is 1528234143, issued by NPPES.
Does Dr. Seth Pollack accept Medicare assignment?
Yes. Dr. Seth Pollack accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Seth Pollack commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.